Fig. 2
From: Neurodegenerative and neuroinflammatory changes in SOD1-ALS patients receiving tofersen
(A,B) Spaghetti plots of ALSFRS-R (A) and DPR (B) individual changes since the baseline for each patient observed. ALSFRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale revised; DPR, disease progression rate.
